Engineered polycationic receptor binding domain of colicin N increased its cytoxicity against human lung cancer cells

被引：0
|
作者：
Duangkaew, M. [1 ]
Taweecheep, P. [1 ]
Chaotham, C. [1 ]
Pornputtapong, N. [1 ]
Arunmanee, W. [1 ]
机构：
[1] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Bangkok, Thailand
来源：
FEBS OPEN BIO | 2021年 / 11卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-07.1-23
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [31] RADIATION INACTIVATION OF ESTROGEN-RECEPTOR IN INTACT HUMAN BREAST-CANCER CELLS (MCF-7) - LACK OF ENERGY-TRANSFER TO THE ESTRADIOL BINDING DOMAIN
    TOULAS, C
    BEAUREGARD, G
    DELASSUS, F
    THAUVETTE, L
    POTIER, M
    BAYARD, F
    FAYE, JC
    FEBS LETTERS, 1991, 285 (01) : 28 - 30
  • [32] Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells
    Wen G. Jiang
    Lin Ye
    Fiona Ruge
    Sioned Owen
    Tracey Martin
    Ping‑Hui Sun
    Andrew J. Sanders
    Jane Lane
    Lucy Satherley
    Hoi P. Weeks
    Yong Gao
    Cong Wei
    Yiling Wu
    Malcolm D. Mason
    Journal of Translational Medicine, 22
  • [33] Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
    Yamanaka, Y
    Fowlkes, JL
    Wilson, EM
    Rosenfeld, RG
    Oh, Y
    ENDOCRINOLOGY, 1999, 140 (03) : 1319 - 1328
  • [34] Differential Mitochondrial, Oxidative Stress and Inflammatory Responses to SARS-CoV-2 Spike Protein Receptor Binding Domain in Human Lung Microvascular, Coronary Artery Endothelial and Bronchial Epithelial Cells
    Kulkoviene, Gabriele
    Narauskaite, Deimante
    Tunaityte, Agile
    Volkeviciute, Augusta
    Balion, Zbigniev
    Kutakh, Olena
    Gecys, Dovydas
    Kairyte, Milda
    Uldukyte, Martyna
    Stankevicius, Edgaras
    Jekabsone, Aiste
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [35] Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the VEGF165 gene
    Weisz, A
    Koren, B
    Cohen, T
    Neufeld, G
    Kleinberger, T
    Lewis, BS
    Flugelman, MY
    CIRCULATION, 2001, 103 (14) : 1887 - 1892
  • [36] Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
    Yang, Shuo
    Cao, Bihui
    Zhou, Guangyu
    Zhu, Lipeng
    Wang, Lu
    Zhang, Li
    Kwok, Hang Fai
    Zhang, Zhenfeng
    Zhao, Qi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [37] Genetically Engineered Measles Virus Edmonston Strain Expressing the Wild-Type N, P, L Genes (MV-NPL) Is a Promising Oncolytic Virotherapy Agent Against Lung Cancer Stem Cells
    Inoue, Hiroyuki
    Yasunari, Keisuke
    Sakamoto, Akira
    Miyamoto, Shohei
    Nosaki, Kaname
    Matsumura, Yumiko
    Nakamura, Takafumi
    Takayama, Koichi
    Nakanishi, Yoichi
    Tani, Kenzaburo
    MOLECULAR THERAPY, 2012, 20 : S95 - S95
  • [38] Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway
    Y Liu
    R Pixley
    M Fusaro
    G Godoy
    E Kim
    M E Bromberg
    R W Colman
    Oncogene, 2009, 28 : 2756 - 2765
  • [39] Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway
    Liu, Y.
    Pixley, R.
    Fusaro, M.
    Godoy, G.
    Kim, E.
    Bromberg, M. E.
    Colman, R. W.
    ONCOGENE, 2009, 28 (30) : 2756 - 2765
  • [40] Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue:: Analysis by Northern blotting and in situ hybridization
    Morita, S
    Sato, A
    Hayakawa, H
    Ihara, H
    Urano, T
    Takada, Y
    Takada, A
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (03) : 286 - 292
12345